Corrigendum: Rewired glycolysis by DTL accelerates oncometabolite L-lactate generation to promote breast cancer progression [0.03%]
correction: DTL介导的糖酵解重编程促进乳腺癌生成和发展乳酸盐的作用机制研究
Yuhao Liu,Jinting Li,Yiren Cao et al.
Yuhao Liu et al.
[This corrects the article DOI: 10.3389/fonc.2025.1583752.]. Keywords: DTL; L-lactate; breast cancer; glycol...
Published Erratum
Frontiers in oncology. 2025 Jun 27:15:1630154. DOI:10.3389/fonc.2025.1630154 2025
Dosimetric evaluation of a novel automated noncoplanar volumetric modulated arc therapy technique for treating optic nerve sheath meningiomas [0.03%]
一种新型的自动化非共面容积调强弧形治疗技术治疗视神经鞘脑膜瘤的剂量学评估研究
Zhenyu Xiong,Chingyun Cheng,Lili Zhou et al.
Zhenyu Xiong et al.
Purpose: This study aimed to evaluate the dosimetric outcomes for the target and organs at risk (OARs) in patients with optic nerve sheath meningiomas (ONSMs), comparing HyperArc (HA), a novel automated noncoplanar volume...
Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions [0.03%]
IDH突变2级胶质瘤的Vorasidenib：临床进展和未来方向
Zhenjiang Pan,Jing Bao,Shepeng Wei
Zhenjiang Pan
Vorasidenib, a brain-penetrant dual inhibitor of mutant isocitrate dehydrogenase 1 and 2 (IDH1/2), represents a significant advancement in the management of IDH-mutant gliomas. This review explores the clinical implications of its recent FD...
Correction: Changes in lymphocyte subsets pre- and post-particle radiotherapy in head and neck bone and soft tissue tumors [0.03%]
订正：头颈部骨及软组织肿瘤粒子放疗前后淋巴细胞亚群的变化
Haojiong Zhang,Jing Gao,Jiyi Hu et al.
Haojiong Zhang et al.
[This corrects the article DOI: 10.3389/fonc.2025.1543718.]. Keywords: bone and soft tissue tumors; head and...
Published Erratum
Frontiers in oncology. 2025 Jun 27:15:1648468. DOI:10.3389/fonc.2025.1648468 2025
Changes in lymphocyte subsets pre- and post-particle radiotherapy in head and neck bone and soft tissue tumors [0.03%]
头颈部骨及软组织肉瘤质子治疗前后的淋巴细胞亚群变化
Haojiong Zhang,Jing Gao,Jiyi Hu et al.
Haojiong Zhang et al.
Purpose: Bone and soft tissue tumors present unique therapeutic challenges due to their heterogeneity and poor prognosis to standard treatments. Particle therapy offers improved dose distribution and potentially higher re...
Investigating the link between APCI1307K mutation and breast cancer in a Jordanian Arab population [0.03%]
探究APCI1307K突变与约旦阿拉伯人乳腺癌之间的联系
Baha Sharaf,Hira Bani Hani,Anas Zayed et al.
Baha Sharaf et al.
Introduction: APCI1307K missense mutation, welldescribed in Ashkenazi Jewish, is commonly encountered among Jordanian patients with solid tumors. In this study, we investigated the potential association between the APC ge...
Renal dysfunction as a predictor of recurrence and prognosis in colorectal cancer [0.03%]
肾功能不全作为结直肠癌复发和预后的预测指标
Xuekang Ren,Shaogong Zhu,Rongzhen Li et al.
Xuekang Ren et al.
Purpose: This study explores the relationship between eGFR and recurrence and prognosis in patients with colorectal cancer (CRC). Methods: ...
Correction: Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer [0.03%]
胃癌预后生物标志物鉴定与验证的更正：单核细胞向巨噬细胞分化的相关性研究
Suyang Bai,Zhaofeng Chen,Rui Ji et al.
Suyang Bai et al.
[This corrects the article DOI: 10.3389/fonc.2025.1508355.]. Keywords: MMD; biomarker; miR-200b-3p; prognosi...
Published Erratum
Frontiers in oncology. 2025 Jun 27:15:1649116. DOI:10.3389/fonc.2025.1649116 2025
Outcomes of extended versus standard lymphadenectomy in pancreatoduodenectomy for pancreatic cancer: systematic review and meta-analysis [0.03%]
扩大淋巴结清扫与标准淋巴结清扫胰十二指肠切除术治疗胰腺癌的系统评价和meta分析
Yu-Chun Xu,Yin-Hao Shi,Xiao-Feng Li
Yu-Chun Xu
Background: Pancreatic cancer has a poor prognosis, and surgical resection is the only curative option. Extended lymphadenectomy (EPD) during pancreatoduodenectomy may improve staging and reduce recurrence, but its surviv...
Tumor-derived exosomal lncRNA SNHG4 promotes triple-negative breast cancer progression by targeting XPO5 [0.03%]
肿瘤来源的外泌体长链非编码RNA SNHG4通过靶向XPO5促进三阴性乳腺癌进展
Zhi-Wen Wang,Hou-Sheng Yang,Hong-Shan Guo et al.
Zhi-Wen Wang et al.
Background: Triple-negative breast cancer (TNBC) is the subtype of advanced breast cancer with the shortest survival time and the poorest prognosis, and treatment options are relatively limited. Exosomes, small extracellu...